Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
157.60    3.80 (2.47%)
Bid:
157.60
Ask:
158.00
Spread: 0.40 (0.254%)
Market Cap: £385.03m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding

22 Oct 2024 14:43

RNS Number : 1748J
Sabre Insurance Group PLC
22 October 2024
Β 

22 October 2024

Β 

Sabre Insurance Group plc

Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Β 

Sabre Insurance Group plc (the "Company" or "Sabre), one of the UK's leading private motor insurance underwriters, announces that it was notified on 22 October 2024 that Geoff Carter, Chief Executive Officer, purchased 7,518 Ordinary Shares of Β£0.001 each in the capital of the Company respectively on the dates below at an average price of 132.33 pence.

Β 

Following the transaction, Mr and Mrs Carter confirm they hold 1,719,714 Ordinary Shares in the Company, representing 0.69 percent of the Company's issued share capital.

Β 

Further details of the Transaction are set out below and in the attached notification as required by the EU Market Abuse Regulation.

Β 

For further information, please contact:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk

Β 

LEI Code: 2138006RXRQ8P8VKGV98

Sabre Insurance Group Plc

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Notification of transactions by Persons Discharging Managerial Responsibilities (PDMR)

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Geoff Carter

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of ordinary shares

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

132.33 pence

7,518

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

7,518

132.33 pence

Β 

e)

Date of transaction

22 October 2024

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHXLLFLZBLZFBL
Date   Source Headline
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
17th Jun 20254:35 pmRNSDirector/PDMR Shareholding
11th Jun 20251:38 pmRNSDirector/PDMR Shareholding
5th Jun 202511:16 amRNSDirector/PDMR Shareholding
22nd May 202511:38 amRNSResult of AGM
22nd May 20257:00 amRNSTrading Update
13th May 20253:18 pmRNSDirector/PDMR Shareholding
17th Apr 20259:40 amRNSDirector/PDMR Shareholding
11th Apr 20251:26 pmRNSDirector/PDMR Shareholding
10th Apr 20251:09 pmRNSDirector/PDMR Shareholding
8th Apr 20254:31 pmRNSDirector/PDMR Shareholding
8th Apr 20253:54 pmRNSDirector/PDMR Shareholding
8th Apr 20251:53 pmRNSDirector/PDMR Shareholding
4th Apr 20253:20 pmRNSNotice of AGM
27th Mar 20258:37 amRNSDirector/PDMR Shareholding
20th Mar 202511:39 amRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results
11th Mar 20251:21 pmRNSDirector/PDMR Shareholding
24th Feb 202511:23 amRNSNotice of Results
11th Feb 20253:12 pmRNSDirector/PDMR Shareholding
13th Jan 20252:14 pmRNSDirector/PDMR Shareholding
11th Dec 202411:57 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSCapital Markets Event
21st Nov 202410:28 amRNSAppointment of Joint Corporate Broker
12th Nov 20241:15 pmRNSDirector/PDMR Shareholding
23rd Oct 20244:13 pmRNSHolding(s) in Company
22nd Oct 20242:43 pmRNSDirector/PDMR Shareholding
22nd Oct 20242:40 pmRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update
18th Oct 20243:25 pmRNSHolding(s) in Company
11th Oct 202412:40 pmRNSDirector/PDMR Shareholding
26th Sep 20241:25 pmRNSDirector/PDMR Shareholding
11th Sep 202412:21 pmRNSDirector/PDMR Shareholding
11th Sep 20249:51 amRNSHolding(s) in Company
6th Sep 20242:29 pmRNSHolding(s) in Company
30th Aug 202411:50 amRNSDirector/PDMR Shareholding
22nd Aug 20244:22 pmRNSHolding(s) in Company
14th Aug 20243:33 pmRNSHolding(s) in Company
13th Aug 202412:48 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSHalf-year Report 2024
22nd Jul 20247:00 amRNSNotice of Results
11th Jul 202412:25 pmRNSDirector/PDMR Shareholding
3rd Jul 20243:40 pmRNSHolding(s) in Company
19th Jun 202412:28 pmRNSAppointment of Non-executive Director
14th Jun 20249:50 amRNSDirector/PDMR Shareholding
11th Jun 202411:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.